Vials Market Research Report: By Glass Type (Borosilicate, Fused-Silica), End User (Pharmaceutical and Biotech Companies, Biomedical Research Organizations, Medical) - Global Industry Forecast to 2030

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Market Size Breakdown by Segment

1.3.1 Market Segmentation by Glass Type

1.3.2 Market Segmentation by End User

1.3.3 Market Segmentation by Geography

1.3.4 Analysis Period

1.3.5 Market Data Reporting Unit

1.3.5.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.1.1 Paid

2.1.2 Unpaid

2.1.3 P&S Intelligence Database

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.2.1.4 By designation

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Currency Conversion Rates

2.6 Assumptions for the Study

2.7 Notes & Caveats

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Glass Type

4.1.1.1 Borosilicate

4.1.1.2 Fused-silica

4.1.2 By End User

4.1.2.1 Pharmaceutical and biotech companies

4.1.2.1.1 By filling technology

4.1.2.1.1.1 Volumetric filling

4.1.2.1.1.2 Liquid-level filling

4.1.2.2 Biomedical research organizations

4.1.2.3 Medical

4.1.2.4 Others

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Increasing preference for glass vials

4.2.2 Drivers

4.2.2.1 Growing pharmaceutical industry

4.2.2.2 Rising production capacity of vial manufacturers

4.2.2.3 Increasing healthcare expenditure

4.2.2.4 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 High cost of vials

4.2.3.2 High risk of breakage

4.2.3.3 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Increasing demand for vaccine packaging

4.3 Porter’s Five Forces Analysis

4.3.1 Bargaining Power of Buyers

4.3.2 Bargaining Power of Suppliers

4.3.3 Intensity of Rivalry

4.3.4 Threat of New Entrants

4.3.5 Threat of Substitutes

4.4 Impact of COVID-19

Chapter 5. Global Market Size and Forecast

5.1 By Glass Type

5.2 By End User

5.2.1 Market for Vials Used by Pharmaceutical and Biotech Companies, by Filling Technology

5.3 By Region

Chapter 6. Europe Market Size and Forecast

6.1 Overview

6.2 By Glass Type

6.3 By End User

6.3.1 Market for Vials Used by Pharmaceutical and Biotech Companies, by Filling Technology

6.4 By Country

6.4.1 Germany Market Size and Forecast

6.4.1.1 By glass type

6.4.1.2 By end user

6.4.1.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

6.4.2 France Market Size and Forecast

6.4.2.1 By glass type

6.4.2.2 By end user

6.4.2.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

6.4.3 U.K. Market Size and Forecast

6.4.3.1 By glass type

6.4.3.2 By end user

6.4.3.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

6.4.4 Italy Market Size and Forecast

6.4.4.1 By glass type

6.4.4.2 By end user

6.4.4.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

6.4.5 Spain Market Size and Forecast

6.4.5.1 By glass type

6.4.5.2 By end user

6.4.5.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

6.4.6 Netherlands Market Size and Forecast

6.4.6.1 By glass type

6.4.6.2 By end user

6.4.6.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

Chapter 7. North America Market Size and Forecast

7.1 Overview

7.2 By Glass Type

7.3 By End User

7.3.1 Market for Vials Used by Pharmaceutical and Biotech Companies, by Filling Technology

7.4 By Country

7.4.1 U.S. Market Size and Forecast

7.4.1.1 By glass type

7.4.1.2 By end user

7.4.1.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

7.4.2 Canada Market Size and Forecast

7.4.2.1 By glass type

7.4.2.2 By end user

7.4.2.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

Chapter 8. APAC Market Size and Forecast

8.1 Overview

8.2 By Glass Type

8.3 By End User

8.3.1 Market for Vials Used by Pharmaceutical and Biotech Companies, by Filling Technology

8.4 By Country

8.4.1 Japan Market Size and Forecast

8.4.1.1 By glass type

8.4.1.2 By end user

8.4.1.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

8.4.2 China Market Size and Forecast

8.4.2.1 By glass type

8.4.2.2 By end user

8.4.2.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

8.4.3 India Market Size and Forecast

8.4.3.1 By glass type

8.4.3.2 By end user

8.4.3.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

8.4.4 Australia Market Size and Forecast

8.4.4.1 By glass type

8.4.4.2 By end user

8.4.4.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

Chapter 9. LATAM Market Size and Forecast

9.1 Overview

9.2 By Glass Type

9.3 By End User

9.3.1 Market for Vials Used by Pharmaceutical and Biotech Companies, by Filling Technology

9.4 By Country

9.4.1 Brazil Market Size and Forecast

9.4.1.1 By glass type

9.4.1.2 By end user

9.4.1.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

9.4.2 Mexico Market Size and Forecast

9.4.2.1 By glass type

9.4.2.2 By end user

9.4.2.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

9.4.3 Argentina Africa Market Size and Forecast

9.4.3.1 By glass type

9.4.3.2 By end user

9.4.3.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

Chapter 10. MEA Market Size and Forecast

10.1 Overview

10.2 By Glass Type

10.3 By End User

10.3.1 Market for Vials Used by Pharmaceutical and Biotech Companies, by Filling Technology

10.4 By Country

10.4.1 Saudi Arabia Market Size and Forecast

10.4.1.1 By glass type

10.4.1.2 By end user

10.4.1.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

10.4.2 U.A.E. Market Size and Forecast

10.4.2.1 By glass type

10.4.2.2 By end user

10.4.2.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

10.4.3 South Africa Market Size and Forecast

10.4.3.1 By glass type

10.4.3.2 By end user

10.4.3.2.1 Market for vials used by pharmaceutical and biotech companies, by filling technology

Chapter 11. Competitive Landscape

11.1 Recent Strategic Developments of Players

11.1.1 Expansions

11.1.2 Product Launches

11.1.3 Agreements and Partnerships

11.2 Market Share Analysis of Key Players

11.3 List of Market Players and Their Offerings

Chapter 12. Company Profiles

12.1 Phoenix Glass LLC

12.1.1 Business Overview

12.1.2 Product and Service Offerings

12.2 Pacific Vial Manufacturing Inc.

12.2.1 Business Overview

12.2.2 Product and Service Offerings

12.3 Hanna Instruments

12.3.1 Business Overview

12.3.2 Product and Service Offerings

12.4 PIRAMIDA d.o.o.

12.4.1 Business Overview

12.4.2 Product and Service Offerings

12.5 O.Berk

12.5.1 Business Overview

12.5.2 Product and Service Offerings

12.6 Acme Vial and Glass Company LLC

12.6.1 Business Overview

12.6.2 Product and Service Offerings

12.7 SGD Pharma

12.7.1 Business Overview

12.7.2 Product and Service Offerings

12.8 Stevanato Group

12.8.1 Business Overview

12.8.2 Product and Service Offerings

12.9 SCHOTT AG

12.9.1 Business Overview

12.9.2 Product and Service Offerings

12.9.3 Key Financial Summary

12.10 Gerresheimer AG

12.10.1 Business Overview

12.10.2 Product and Service Offerings

12.10.3 Key Financial Summary

12.11 Corning Incorporated

12.11.1 Business Overview

12.11.2 Product and Service Offerings

12.11.3 Key Financial Summary

12.12 Amposan S.A.

12.12.1 Business Overview

12.12.2 Product and Service Offerings

12.13 TricorBraun Inc.

12.13.1 Business Overview

12.13.2 Product and Service Offerings

12.14 Borosil Limited

12.14.1 Business Overview

12.14.2 Product and Service Offerings

12.14.3 Key Financial Summary

12.15 Piramal Glass Limited

12.15.1 Business Overview

12.15.2 Product and Service Offerings

12.16 Nipro Corporation

12.16.1 Business Overview

12.16.2 Product and Service Offerings

12.16.3 Key Financial Summary

12.17 PerkinElmer Inc.

12.17.1 Business Overview

12.17.2 Product and Service Offerings

12.17.3 Key Financial Summary

12.18 Thermo Fisher Scientific Inc.

12.18.1 Business Overview

12.18.2 Product and Service Offerings

12.18.3 Key Financial Summary

Chapter 13. Appendix

13.1 Abbreviations

13.2 Sources and References

13.3 Related Report

 

LIST OF TABLES

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 GLOBAL VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 5 GLOBAL VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 6 GLOBAL VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 7 GLOBAL VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 8 GLOBAL MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 9 GLOBAL MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 10 GLOBAL VIALS MARKET, BY REGION, $M (2014–2020)

TABLE 11 GLOBAL VIALS MARKET, BY REGION, $M (2021–2030)

TABLE 12 EUROPE VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 13 EUROPE VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 14 EUROPE VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 15 EUROPE VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 16 EUROPE MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 17 EUROPE MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 18 EUROPE VIALS MARKET, BY COUNTRY, $M (2014–2020)

TABLE 19 EUROPE VIALS MARKET, BY COUNTRY, $M (2021–2030)

TABLE 20 GERMANY VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 21 GERMANY VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 22 GERMANY VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 23 GERMANY VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 24 GERMANY MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 25 GERMANY MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 26 FRANCE VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 27 FRANCE VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 28 FRANCE VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 29 FRANCE VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 30 FRANCE MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 31 FRANCE MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 32 U.K. VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 33 U.K. VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 34 U.K. VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 35 U.K. VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 36 U.K. MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 37 U.K. MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 38 ITALY VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 39 ITALY VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 40 ITALY VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 41 ITALY VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 42 ITALY MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 43 ITALY MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 44 SPAIN VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 45 SPAIN VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 46 SPAIN VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 47 SPAIN VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 48 SPAIN MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 49 SPAIN MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 50 NETHERLANDS VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 51 NETHERLANDS VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 52 NETHERLANDS VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 53 NETHERLANDS VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 54 NETHERLANDS MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 55 NETHERLANDS MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 56 NORTH AMERICA VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 57 NORTH AMERICA VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 58 NORTH AMERICA VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 59 NORTH AMERICA VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 60 NORTH AMERICA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 61 NORTH AMERICA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 62 NORTH AMERICA VIALS MARKET, BY COUNTRY, $M (2014–2020)

TABLE 63 NORTH AMERICA VIALS MARKET, BY COUNTRY, $M (2021–2030)

TABLE 64 U.S. VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 65 U.S. VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 66 U.S. VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 67 U.S. VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 68 U.S. MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 69 U.S. MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 70 CANADA VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 71 CANADA VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 72 CANADA VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 73 CANADA VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 74 CANADA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 75 CANADA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 76 APAC VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 77 APAC VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 78 APAC VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 79 APAC VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 80 APAC MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 81 APAC MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 82 APAC VIALS MARKET, BY COUNTRY, $M (2014–2020)

TABLE 83 APAC VIALS MARKET, BY COUNTRY, $M (2021–2030)

TABLE 84 JAPAN VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 85 JAPAN VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 86 JAPAN VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 87 JAPAN VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 88 JAPAN MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 89 JAPAN MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 90 CHINA VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 91 CHINA VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 92 CHINA VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 93 CHINA VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 94 CHINA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 95 CHINA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 96 INDIA VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 97 INDIA VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 98 INDIA VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 99 INDIA VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 100 INDIA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 101 INDIA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 102 AUSTRALIA VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 103 AUSTRALIA VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 104 AUSTRALIA VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 105 AUSTRALIA VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 106 AUSTRALIA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 107 AUSTRALIA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 108 LATAM VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 109 LATAM VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 110 LATAM VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 111 LATAM VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 112 LATAM MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 113 LATAM MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 114 LATAM VIALS MARKET, BY COUNTRY, $M (2014–2020)

TABLE 115 LATAM VIALS MARKET, BY COUNTRY, $M (2021–2030)

TABLE 116 BRAZIL VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 117 BRAZIL VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 118 BRAZIL VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 119 BRAZIL VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 120 BRAZIL MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 121 BRAZIL MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 122 MEXICO VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 123 MEXICO VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 124 MEXICO VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 125 MEXICO VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 126 MEXICO MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 127 MEXICO MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 128 ARGENTINA VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 129 ARGENTINA VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 130 ARGENTINA VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 131 ARGENTINA VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 132 ARGENTINA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 133 ARGENTINA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 134 MEA VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 135 MEA VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 136 MEA VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 137 MEA VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 138 MEA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 139 MEA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 140 MEA VIALS MARKET, BY COUNTRY, $M (2014–2020)

TABLE 141 MEA VIALS MARKET, BY COUNTRY, $M (2021–2030)

TABLE 142 SAUDI ARABIA VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 143 SAUDI ARABIA VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 144 SAUDI ARABIA VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 145 SAUDI ARABIA VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 146 SAUDI ARABIA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 147 SAUDI ARABIA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 148 U.A.E. VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 149 U.A.E. VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 150 U.A.E. VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 151 U.A.E. VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 152 U.A.E. MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 153 U.A.E. MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 154 SOUTH AFRICA VIALS MARKET, BY GLASS TYPE, $M (2014–2020)

TABLE 155 SOUTH AFRICA VIALS MARKET, BY GLASS TYPE, $M (2021–2030)

TABLE 156 SOUTH AFRICA VIALS MARKET, BY END USER, $M (2014–2020)

TABLE 157 SOUTH AFRICA VIALS MARKET, BY END USER, $M (2021–2030)

TABLE 158 SOUTH AFRICA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2014–2020)

TABLE 159 SOUTH AFRICA MARKET FOR VIALS USED BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY FILLING TECHNOLOGY, $M (2021–2030)

TABLE 160 LIST OF MARKET PLAYERS AND THEIR OFFERINGS

TABLE 161 PHOENIX GLASS LLC – AT A GLANCE

TABLE 162 PACIFIC VIAL MANUFACTURING INC. – AT A GLANCE

TABLE 163 HANNA INSTRUMENTS – AT A GLANCE

TABLE 164 PIRAMIDA D.O.O. – AT A GLANCE

TABLE 165 O.BERK – AT A GLANCE

TABLE 166 ACME VIAL AND GLASS COMPANY LLC – AT A GLANCE

TABLE 167 SGD PHARMA – AT A GLANCE

TABLE 168 STEVANATO GROUP – AT A GLANCE

TABLE 169 SCHOTT AG – AT A GLANCE

TABLE 170 SCHOTT AG – KEY FINANCIAL SUMMARY

TABLE 171 GERRESHEIMER AG – AT A GLANCE

TABLE 172 GERRESHEIMER AG – KEY FINANCIAL SUMMARY

TABLE 173 CORNING INCORPORATED – AT A GLANCE

TABLE 174 CORNING INCORPORATED – KEY FINANCIAL SUMMARY

TABLE 175 AMPOSAN S.A. – AT A GLANCE

TABLE 176 TRICORBRAUN INC. – AT A GLANCE

TABLE 177 BOROSIL LIMITED – AT A GLANCE

TABLE 178 BOROSIL LIMITED – KEY FINANCIAL SUMMARY

TABLE 179 PIRAMAL GLASS LIMITED – AT A GLANCE

TABLE 180 NIPRO CORPORATION – AT A GLANCE

TABLE 181 NIPRO CORPORATION – KEY FINANCIAL SUMMARY

TABLE 182 PERKINELMER INC. – AT A GLANCE

TABLE 183 PERKINELMER INC. – KEY FINANCIAL SUMMARY

TABLE 184 THERMO FISHER SCIENTIFIC INC. – AT A GLANCE

TABLE 185 THERMO FISHER SCIENTIFIC INC. – KEY FINANCIAL SUMMARY

 

LIST OF FIGURES

 

FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 BREAKDOWN OF PRIMARY RESEARCH BY DESIGNATION

FIG 8 DATA TRIANGULATION APPROACH

FIG 9 CURRENCY CONVERSION RATES FOR USD (2020)

FIG 10 GLOBAL VIALS MARKET EXECUTIVE SUMMARY

FIG 11 GLOBAL HEALTHCARE EXPENDITURE PER CAPITA, $ (2015–2018)

FIG 12 BARGAINING POWER OF BUYERS

FIG 13 BARGAINING POWER OF SUPPLIERS

FIG 14 INTENSITY OF RIVALRY

FIG 15 THREAT OF NEW ENTRANTS

FIG 16 THREAT OF SUBSTITUTES

FIG 17 GLOBAL VIALS MARKET SNAPSHOT

FIG 18 GLOBAL VIALS MARKET, BY GLASS TYPE, $M (2014–2030)

FIG 19 GLOBAL VIALS MARKET, BY END USER, $M (2014–2030)

FIG 20 MAJOR MARKETS FOR VIALS

FIG 21 EUROPE VIALS MARKET, BY GLASS TYPE, $M (2014–2030)

FIG 22 EUROPE VIALS MARKET, BY END USER, $M (2014–2030)

FIG 23 EUROPE VIALS MARKET, BY COUNTRY, $M (2014–2030)

FIG 24 NORTH AMERICA VIALS MARKET, BY GLASS TYPE, $M (2014–2030

FIG 25 NORTH AMERICA VIALS MARKET, BY END USER, $M (2014–2030)

FIG 26 NORTH AMERICA VIALS MARKET, BY COUNTRY, $M (2014–2030)

FIG 27 APAC VIALS MARKET, BY GLASS TYPE, $M (2014–2030)

FIG 28 APAC VIALS MARKET, BY END USER, $M (2014–2030)

FIG 29 APAC VIALS MARKET, BY COUNTRY, $M (2014–2030)

FIG 30 LATAM VIALS MARKET, BY GLASS TYPE, $M (2014–2030)

FIG 31 LATAM VIALS MARKET, BY END USER, $M (2014–2030)

FIG 32 LATAM VIALS MARKET, BY COUNTRY, $M (2014–2030)

FIG 33 MEA VIALS MARKET, BY GLASS TYPE, $M (2014–2030)

FIG 34 MEA VIALS MARKET, BY END USER, $M (2014–2030)

FIG 35 MEA VIALS MARKET, BY COUNTRY, $M (2014–2030)

FIG 36 GLOBAL VIALS MARKET SHARE OF KEY PLAYERS (2020)

FIG 37 SCHOTT AG – REVENUE SPLIT BY GEOGRAPHY (2020)

FIG 38 GERRESHEIMER AG – REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2020)

FIG 39 CORNING INCORPORATED – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)

FIG 40 BOROSIL LIMITED – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)

FIG 41 NIPRO CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)

FIG 42 PERKINELMER INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)

FIG 43 THERMO FISHER SCIENTIFIC INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)